Exploring Key Insights of the Preimplantation Genetic Testing Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the preimplantation genetic testing market right now?
In recent times, there has been a significant expansion in the preimplantation genetic testing market. It is projected to boost from a market size of $0.83 billion in 2024 to a worth of $0.92 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.6%. This historical growth pattern is a result of a rise in genetic disorder cases, heightened awareness about genetic testing, expansion in prenatal testing avenues, amplified demand for individualized treatments, as well as a heightened emphasis on preemptive healthcare strategies.
How fast Is the preimplantation genetic testing market expected to grow, and what’s its future value?
Over the next several years, the preimplantation genetic testing market is anticipated to witness a swift expansion, reaching a value of $1.41 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. This surge over the predicted timeframe is linked to several factors such as the escalating count of fertility clinics, expansion in genetic counseling services, an increase in the occurrence of advanced maternal age, broader availability of sophisticated genetic testing systems, and the growth in PGT applications. The coming years will likely also see major trends such as the uptake of cutting-edge sequencing technologies, incorporation of broader genetic panels, evolution of non-invasive testing techniques, progress in embryo culture systems, and improvements in genetic editing technologies.
Get your preimplantation genetic testing market report here!
What are the leading drivers of growth in the preimplantation genetic testing market?
The escalation in procedures pertaining to in vitro fertilization (IVF) is predicted to bolster the development of the preimplantation genetic testing market in the future. IVF methods comprising fertilization of eggs with sperm externally to form an embryo, which is later positioned in the uterus. This rise in IVF procedures is fuelled by advancements in reproductive technology, climbing infertility rates, and increased public cognizance. The burgeoning IVF procedures amplifies the preimplantation genetic testing market by growing the need for genetic examination of embryos ahead of implantation. For instance, in April 2024, the Society for Assisted Reproductive Technology, a US-based establishment, reported that in 2022, 91,771 babies took birth via in vitro fertilization (IVF). Hence, the upsurge in in vitro fertilization (IVF) procedures is steering the preimplantation genetic testing market.
What are the key segments defining the preimplantation genetic testing market?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
Who are the key players steering the development of the preimplantation genetic testing market?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd., Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC
What emerging trends are influencing the growth of the preimplantation genetic testing market?
Leading corporations in the preimplantation genetic testing market are innovating advanced next-generation sequencing (NGS) tools, a move set to increase precision, efficiency, and speed in genetic examination and offer in-depth evaluations for potential parents. These next-generation sequencing (NGS) resources catalyze genetic studies via expedited, high-capacity scrutiny of DNA and RNA, yielding comprehensive knowledge on genetic variations and gene expression. This consequently improves precision and paves the way for customized medicine. For illustration, Thermo Fisher Scientific, a notable U.S. biotechnology firm, in July 2023, unveiled the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These advanced NGS tools aim to boost IVF and ICSI scrutiny. Efficiently consolidating workflows from handling samples to aneuploidy study with pioneering technology on the ion torrent genexus integrated sequencer, they represent a notable progression in the preimplantation genetic testing market, refining embryo assessment and increasing success percentages in assisted reproductive technologies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20596
Which regions are most influential in expanding the preimplantation genetic testing market?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Direct-To-Consumer (Dtc) Genetic Testing Global Market Report 2025
Genetically Modified Fruits Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report
Optogenetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
